Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy

被引:624
作者
Ommen, SR
Maron, BJ
Olivotto, I
Maron, MS
Cecchi, F
Betocchi, S
Gersh, BJ
Ackerman, MJ
McCully, RB
Dearani, JA
Schaff, HV
Danielson, GK
Tajik, AJ
Nishimura, RA
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA
[3] Azienda Osped Careggi, Reg Referal Ctr Myocardial Dis, Florence, Italy
[4] Tufts Univ, New England Med Ctr, Hypertroph Cardiomyopathy Ctr, Div Cardiol, Boston, MA 02111 USA
[5] Univ Naples Federico II, Dept Clin Med Cardiovasc & Immunol Sci, Naples, Italy
关键词
D O I
10.1016/j.jacc.2005.02.090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine the impact of surgical myectomy on long-term survival in hypertrophic cardiomyopathy (HCM). BACKGROUND Left ventricular (LV) outflow tract obstruction in HCM increases the likelihood of heart failure and cardiovascular death. Although surgical myectomy is the primary treatment for amelioration of outflow obstruction and advanced drug-refractory heart failure symptoms, its impact on long-term survival remains unresolved. METHODS Total and HCM-related mortality were compared in three subgroups comprised of 1,337 consecutive HCM patients evaluated from 1983 to 2001: 1) surgical myectomy (n = 289); 2) LV outflow obstruction without operation (n = 228), and 3) nonobstructive (n = 820). Mean follow-up duration was 6 6 years. RESULTS Including two operative deaths (procedural mortality, 0.8%), 1-, 5-, and 10-year overall survival after myectomy was 98%, 96%, and 83%, respectively, and did not differ from that of the general U.S. population matched for age and gender (p = 0.2) nor from patients with nonobstructive HCM (p = 0.8). Compared to nonoperated obstructive HCM patients, myectomy patients experienced superior survival free from all-cause mortality (98%, 96%, and 83% vs. 90%, 79%, and 61%, respectively, p < 0.001), HCM-related mortality (99%, 98%, and 95% vs. 94%, 89%, and 73%, respectively, p < 0.001), and sudden cardiac death (100%, 99%, and 99% vs. 97%, 93%, and 89%, respectively, p = 0.003). Multivariate analysis showed myectomy to have a strong, independent association with survival (hazard ratio 0.43; p < 0.001). CONCLUSIONS Surgical myectomy performed to relieve outflow obstruction and severe symptoms in HCM was associated with long-term survival equivalent to that of the general population, and superior to obstructive HCM without operation. In this retrospective study, septal myectomy seems to reduce mortality risk in severely symptomatic patients with obstructive HCM.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 37 条
  • [1] HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - 10-YEAR TO 21-YEAR FOLLOW-UP AFTER PARTIAL SEPTAL MYECTOMY
    BEAHRS, MM
    TAJIK, AJ
    SEWARD, JB
    GIULIANI, ER
    MCGOON, DC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (07) : 1160 - 1166
  • [2] EFFECT OF SURGICAL REDUCTION OF LEFT-VENTRICULAR OUTFLOW OBSTRUCTION ON HEMODYNAMICS, CORONARY FLOW, AND MYOCARDIAL-METABOLISM IN HYPERTROPHIC CARDIOMYOPATHY
    CANNON, RO
    MCINTOSH, CL
    SCHENKE, WH
    MARON, BJ
    BONOW, RO
    EPSTEIN, SE
    [J]. CIRCULATION, 1989, 79 (04) : 766 - 775
  • [3] LONG-TERM FOLLOW-UP OF PATIENTS UNDERGOING MYOTOMY MYECTOMY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    COHN, LH
    TREHAN, H
    COLLINS, JJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (06) : 657 - 660
  • [4] Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy - A comparison of clinical, haemodynamic and exercise outcomes
    Firoozi, S
    Elliott, PM
    Sharma, S
    Murday, A
    Brecker, SJ
    Hamid, MS
    Sachdev, B
    Thaman, R
    McKenna, WJ
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 (20) : 1617 - 1624
  • [5] SURGICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - EARLY AND LATE RESULTS
    HERIC, B
    LYTLE, BW
    MILLER, DP
    ROSENKRANZ, ER
    LEVER, HM
    COSGROVE, DM
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) : 195 - 208
  • [6] SURGICAL RELIEF OF DIFFUSE SUBVALVULAR AORTIC STENOSIS
    KIRKLIN, JW
    ELLIS, FH
    [J]. CIRCULATION, 1961, 24 (04) : 739 - &
  • [7] PHENOTYPIC SPECTRUM AND PATTERNS OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTROPHIC CARDIOMYOPATHY - MORPHOLOGIC OBSERVATIONS AND SIGNIFICANCE AS ASSESSED BY 2-DIMENSIONAL ECHOCARDIOGRAPHY IN 600 PATIENTS
    KLUES, HG
    SCHIFFERS, A
    MARON, BJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) : 1699 - 1708
  • [8] MARON BJ, 1983, EUR HEART J, V4, P175, DOI 10.1093/eurheartj/4.suppl_F.175
  • [9] Hypertrophic cardiomyopathy - A systematic review
    Maron, BJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10): : 1308 - 1320
  • [10] Maron BJ, 2000, CIRCULATION, V102, P858